With Pataday Extra Strength, Alcon Eyes Consumers Looking For OTC 24-Hour Eye Allergy Remedy
Pataday Once Daily Relief Extra Strength is the same formulation as Novartis' Rx Pazeo. It will be the first OTC eye drop indicated for allergy itch with 24-hour efficacy, available online in September and through retailers in early 2021.
You may also be interested in...
With Pataday Once Daily Relief (0.2% olopatadine) and Twice Daily (0.1%), Alcon adds allergy treatment to its lineup of OTC drops indicated for dry eye and redness. “Obviously, eye allergy will become a much bigger part of the portfolio for us,” says US vision care GM Sean Clark.
Approval Briefs: Zohydro ER, Vyvanse For Binge Eating, Another Imbruvica Claim, Alcon Gains New Allergy Eye Drop
Reformulated opioid still doesn’t have abuse deterrence claim; Shire gains another indication for Vyvanse, this time in binge-eating; Imbruvica becomes the first drug approved for Waldenstrom’s macroglobulinemia; and, Alcon garners approval for once-daily eye drop.
While FDA continues posting announcements of recalls of hand sanitizers made by firms in Mexico and found to contain methanol, its latest recall records update also show Michigan Herbal Remedies recalled a total of 5,938 bottles of hemp oils due to elevated lead levels.